1. Home
  2. EVOK vs LRHC Comparison

EVOK vs LRHC Comparison

Compare EVOK & LRHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVOK
  • LRHC
  • Stock Information
  • Founded
  • EVOK 2007
  • LRHC 2004
  • Country
  • EVOK United States
  • LRHC United States
  • Employees
  • EVOK N/A
  • LRHC N/A
  • Industry
  • EVOK Biotechnology: Pharmaceutical Preparations
  • LRHC
  • Sector
  • EVOK Health Care
  • LRHC
  • Exchange
  • EVOK Nasdaq
  • LRHC Nasdaq
  • Market Cap
  • EVOK 5.4M
  • LRHC 5.2M
  • IPO Year
  • EVOK 2013
  • LRHC 2023
  • Fundamental
  • Price
  • EVOK $5.12
  • LRHC $5.91
  • Analyst Decision
  • EVOK
  • LRHC
  • Analyst Count
  • EVOK 0
  • LRHC 0
  • Target Price
  • EVOK N/A
  • LRHC N/A
  • AVG Volume (30 Days)
  • EVOK 104.5K
  • LRHC 352.1K
  • Earning Date
  • EVOK 08-14-2025
  • LRHC 08-26-2025
  • Dividend Yield
  • EVOK N/A
  • LRHC N/A
  • EPS Growth
  • EVOK N/A
  • LRHC N/A
  • EPS
  • EVOK N/A
  • LRHC N/A
  • Revenue
  • EVOK $12,794,859.00
  • LRHC $73,874,281.00
  • Revenue This Year
  • EVOK $57.82
  • LRHC N/A
  • Revenue Next Year
  • EVOK $59.12
  • LRHC N/A
  • P/E Ratio
  • EVOK N/A
  • LRHC N/A
  • Revenue Growth
  • EVOK 70.02
  • LRHC 90.36
  • 52 Week Low
  • EVOK $1.94
  • LRHC $4.33
  • 52 Week High
  • EVOK $12.32
  • LRHC $142.40
  • Technical
  • Relative Strength Index (RSI)
  • EVOK 55.77
  • LRHC 43.83
  • Support Level
  • EVOK $4.61
  • LRHC $4.89
  • Resistance Level
  • EVOK $5.70
  • LRHC $5.60
  • Average True Range (ATR)
  • EVOK 0.52
  • LRHC 0.61
  • MACD
  • EVOK -0.03
  • LRHC 0.19
  • Stochastic Oscillator
  • EVOK 71.01
  • LRHC 50.16

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

About LRHC La Rosa Holdings Corp.

La Rosa Holdings Corp operates in the U.S. residential real estate market. It is a holding company for agent-centric, technology-integrated, cloud-based, multi-service real estate companies. The company's business is organized based on the services it provides internally to the agents and to the public, which are residential and commercial real estate brokerage, franchising, real estate brokerage education and coaching, and property management. The company has six reportable segments, namely: Real Estate Brokerage Services (Residential), Franchising Services, Coaching Services, Property Management, Real Estate Brokerage Services (Commercial), and Title Settlement and Insurance. It derives maximum revenue from the Real Estate Brokerage Services (Residential) segment.

Share on Social Networks: